The cost of market timing revealed
UK INVESTORS are losing an average of 1.2 percentage points a year because of market timing errors, according to new research from Cass Business School.The study, which was compiled by Andrew Clare...
UK INVESTORS are losing an average of 1.2 percentage points a year because of market timing errors, according to new research from Cass Business School.The study, which was compiled by Andrew Clare...
JLT Benefit Solutions has teamed up with Scottish Widows to launch a GPP offering it says will make the type of services only usually enjoyed by larger DC arrangements available to smaller...
Aviva is offering total reward statements alongside group personal pensions through a tie-up with Staffcare.Statements will carry individual companies’ branding and give staff a personal statement of their benefits package including salary,...
Only one in four people are saving for retirement, but more would if pensions offered guaranteed returns, according to research from Defaqto.The research shows only 40 per cent are actually saving for...
The Treasury Select Committee’s consultation into the Retail Distribution Review could lead to significant changes into the way it is implemented in the group arena say advisers.Michael Whitfield, chief executive of Thomsons...
Legal & General has unveiled two new initiatives to facilitate auto-enrolment into trust-based schemes in a way that is compliant with the requirements published by the government on 27 October last year.Its...
Whenever I think about the concept of pooled risk, I get a hard lump in my chest. It speaks of everything that is good and honourable about mankind. A willingness to club...
It’s not very surprising, but is always disappointing when you hear it. Employees don’t understand or value pensions. There, we’ve said it. Not too hard was it? The extent of the lack...
Last year’s launch of the iPhone 4 showed just how much excitement a new product can create. The fact it was a reincarnation of previous models did not seem to deter consumers’...
Cancer care is under the spotlight again with the government announcing a cancer drugs fund of £200m a year, but advisers remain sceptical about whether this is enough for it to be...